DCGI
Latest news and video coverage curated from trusted media outlets
![Indian government bans Common Cold and Flu Syrups for kids below 4 years | Oneindia News [Video]](https://video.newsserve.net/300/v/20231221/1362498000-Indian-government-bans-Common-Cold-and-Flu-Syrups.jpg) Indian government bans Common Cold and Flu Syrups for kids below 4 years | Oneindia News Credit: Oneindia Duration: 03:23Published | |
![DCGI Rec. Message: Local Missions Sunday [Video]](https://video.newsserve.net/300/v/20240121/1705876174-DCGI-Rec-Message-Local-Missions-Sunday.jpg)
You Might Like
Corbevax Covid booster expected to get final approval from government soon: ReportEarlier on June 4, DCGI approved Corbevax as a precaution dose for those aged 18 and above.DNA - Published | |
Bharat Biotech's intranasal Covid-19 vaccine to get DCGI nod soon? Here's what we knowThe Drug Controller General of India gave its nod to conduct clinical trials for BBIL's intranasal vaccine as a booster dose.DNA - Published | |
India's first qHPV vaccine against cervical cancer gets DCGI's nodnewKerala.com - Published | |
DCGI approves India's first qHPV vaccine to treat cervical cancernewKerala.com - Published | |
DCGI grants marketing authorisation to SII’s qHPV vaccine against cervical cancerIndian Express - Published | |
DCGI approves indigenous mRNA Covid jab for emergency use in 18 yrs & above; Covovax for 7-11 yrsIndian Express - Published | |
DCGI grants emergency use authorisation to India's first mRNA Covid-19 vaccine: SourcesThe Subject Expert Committee under India's drug regulator has found data submitted by Gennova Biopharmaceuticals "satisfactory".DNA - Published | |
Covid-19 vaccine: SII's Covovax gets nod for emergency use in children aged 7 to 11 yearsThe DCGI had approved Covovax for restricted emergency use in adults on December 28, 2021, and in 12-17 years age group on March 9, 2022.DNA - Published Also reported by •IndiaTimes •Zee News | |
India's first mRNA Covid-19 vaccine to get Emergency Use Authorisation soonThe Subject Expert Committee (SEC) in a meeting held on Friday recommended Emergency Use Authorisation (EUA) for India's first mRNA COVID-19 vaccine, sources have said. The Drugs controller general of..IndiaTimes - Published | |
Allowing Corbevax as booster for those vaccinated with Coivishield, Covaxin likely to be considered by NTAGIThe Drugs Controller General of India (DCGI) on June 4 approved Corbevax as a precaution dose for those aged 18 and above. India's first indigenously-developed RBD protein subunit vaccine, Corbevax, is..IndiaTimes - Published | |
Government panel recommends emergency approval of Serum Institute’s Covovax for 7-11 year age group"The Subject Expert Committee of Drugs Controller General Of India (DCGI) has recommended Serum Institute of India`s (SII) vaccine Covovax for children in the age group of 7-11 years," sources..Zee News - Published Also reported by •IndiaTimes | |
Bharat Biotech's Covid nasal vaccine phase 3 trials completedThe company will submit its data to the Drugs Controller General of India (DCGI) next month, said Dr Krishna Ella, Bharat Biotech chief.DNA - Published | |
Corbevax gets DCGI nod as heterologous booster for adultsnewKerala.com - Published | DCGI approves Corbevax as first heterologous COVID-19 booster shot for adultsnewKerala.com - Published |
Your Daily Wrap: Big jolt for Cong in Punjab, Corbevax gets DCGI nod as India’s first heterologous booster Covid vaccine; and moreIndian Express - Published | CORBEVAX becomes first vaccine in India to get DCGI approval for COVID-19 booster doseCORBEVAX has become the first vaccine in India to get DCGI approval for COVID-19 booster dose.Zee News - Published |
DCGI okays Corbevax as India’s first heterologous booster vaccine for CovidIndian Express - Published | DCGI clears Corbevax as Covid booster shot for those aged 18 and aboveIn April, DCGI had given emergency use authorisation (EUA) to Corbevax for children between 5 and 12 years.DNA - Published |
Bharat Biotech seeks DCGI's permission to conduct Covaxin booster trials in 2-18 age groupnewKerala.com - Published | Bharat Biotech seeks DCGI nod for phase 2/3 Covaxin booster trial among two to 18-year-oldBharat Biotech has sought permission from India's drug regulator to conduct a phase 2/3 study of its Covid vaccine Covaxin as a booster dose among those aged two to 18 years, sources told PTI...IndiaTimes - Published |
Covid vaccines for kids below 12 get DCGI nod: All you need to knowIndian Express - Published | BMC plans to rope in paediatricians for vax drive of 6-12 years age group A health department official said, `We already have the centres and the staff. As of now, DCGI has approved vaccines for emergency use. But we still need a nod and guidelines from the Centre`Mid-Day - Published |
DCGI gives emergency use authorisation to Covaxin for 6-12 age groupnewKerala.com - Published | DCGI approves COVID-19 vaccine Covaxin for children aged 6-12newKerala.com - Published |
DCGI grants EUA to ZycovD COVID vaccine for two-dose regimen for children above 12newKerala.com - Published | DCGI grants EUA to 3 Covid vaccines for different age group of childrennewKerala.com - Published |
Covaxin gets DCGI nod for 6-12 age group, Corbevax for 5-12 year oldsIndian Express - Published | BREAKING: DCGI gives emergency use nod to Covaxin for kids aged 6-12 amid fourth wave scareThe Drugs Controller General of India (DCGI) has given a restricted emergency use authorisation to Bharat Biotech's Covaxin for children aged 6-12 years, ANI news agency reported on Tuesday (April 26,..Zee News - Published |
DCGI gives approval for Bharat Biotech's Covaxin for children aged 6-12The Drug Controller General of India (DCGI) has given a restricted emergency use approval for Bharat Biotech's Covid-19 vaccine, Covaxin, for children between the age of six and 12. A Subject Expert..IndiaTimes - Published Also reported by •DNA | DCGI grants approval to Corbevax for kids aged 5-12, Covaxin for 6-12 age groupThe Drug Controller General of India (DCGI) on Tuesday granted emergency use approval to Covid-19 vaccines, Covaxin and Corbevax, for children below 12. Bharat Biotech's Covaxin has got nod for use in..IndiaTimes - Published |
Bharat Biotech asked to provide more data on Covid-19 vaccine Covaxin for children aged below 12The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) has asked Bharat Biotech for additional data on its Covid-19 vaccine, Covaxin, for administering it to children aged..IndiaTimes - Published | Expert panel of DCGI holds meet to discuss recommendations to use COVID-19 vaccines Corbevax, Covaxin for 5-12 age groupnewKerala.com - Published |
Novavax says its Covid vaccine gets India authorisation for adolescentsNovavax Inc on Tuesday said that the Drugs Controller General of India (DCGI) has granted emergency use authorisation for its Covid-19 vaccine for adolescents aged 12 to 17 in the country. The..IndiaTimes - Published | Phase 2,3 trial data of India's first mRNA Covid vaccine submitted to DCGIPune-based Gennova Biopharmaceuticals has submitted the phase-II and phase-III trials data of India's first mRNA Covid vaccine to the regulator Drugs Controller General of India (DCGI) on Friday, said..IndiaTimes - Published Also reported by •newKerala.com |
Covid-19: Covovax gets DCGI’s EUA nod for 12-17-year-oldsIn a move that will further expand the basket of Covid vaccines approved for adolescents, the drug regulator has given emergency approval to Serum Institute of India’s Covovax for use in 12-17 year..IndiaTimes - Published | DCGI grants emergency use authorisation to SII's COVID-19 vaccine Covovax for children aged above 12 yearsnewKerala.com - Published |
DCGI's EUA nod to Covovax for 12-17 years age groupIndia's drug regulator has granted restricted emergency use authorisation to Serum Institute of India's COVID-19 vaccine Covovax for the 12-17 years age group subject to certain conditions, official..IndiaTimes - Published Also reported by •Indian Express | Biological E seeks EUA for Covid vaccine Corbevax for children in 5-12 age group: Official sourcesRecently, the subject expert committee recommended emergency use authorization (EUA) for Biological E's Covid-19 vaccine Corbevax for the age group of 12 to 18 years under certain conditions. The drugs..IndiaTimes - Published |
Zydus Lifesciences gets DCGI approval for Oxemia drugnewKerala.com - Published | Covid-19: SII's Covovax vaccine recommended for Phase 3 trial as booster dose in adultsThe Pune-based SII had sought the permission from the DCGI to conduct Phase 3 study to evaluate the safety and immunogenicity of Covovax.DNA - Published |
